Fact CheckerSign in

NCT07316062Recruiting

A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China

A Multi-centre Chart Review Study on the Treatment Patterns and Outcomes of Stage I-III Non-Small Cell Lung Cancer in China

Source: ClinicalTrials.gov · Last updated 21 Oct 2026

Brief summary (registry, in English)

This chart review study is proposed in China to understand the treatment patterns, biomarker testing, and clinical outcomes with SOC and some selected regimens among patients diagnosed with stage I-III NSCLC.

Status (registry)
Recruiting
Study type
Observational
Enrollment
3000 (estimated)
First submitted
5 Dec 2025
Start date
Apr 2026
Primary completion date
Apr 2029
Lead sponsor
AstraZeneca
Diseases
Lung cancer
NCT number
NCT07316062

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From Apr 2026 to the primary completion date, Apr 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with a recent history of other tumor or concurrent other tumor

Other illness

  • NSCLC is not the primary cancer diagnosis

Other

  • Patients participating in interventional clinical trials at time of initial diagnosis
  • Patients with positive pregnancy status at the time of diagnosis

Who the study is looking for

  • Stage I-III at initial NSCLC diagnosis
  • Aged ≥18 years at first diagnosis of NSCLC
  • Timeframe of NSCLC diagnosis:
    • For DE1: diagnosed with NSCLC during the period between May 1st 2025 and December 31st 2025 For DE2: diagnosed with NSCLC during the period between May 1st 2026 and December 31st 2026 For DE3: diagnosed with NSCLC during the period between May 1st 2027 and December 31st 2027

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
-
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.